The Netherlands contributes € 180 million to end tuberculosis, HIV and malaria

The Netherlands is contributing €180 million to the worldwide fight against tuberculosis (TB), HIV/AIDS and malaria. Minister Liesje Schreinemacher of Development Cooperation announced this yesterday during the 7th replenishment conference of the Global Fund in New York. The Global Fund is an international collaboration with the goal to end TB, HIV and malaria.

With the contribution of € 180 million, the Netherlands will support the Global Fund with € 24 million more over the next 3 years than they do now. This is a formidable contribution to the end of TB and the strengthening of health systems in the countries supported. This makes the Global Fund the largest recipient of Dutch development money in the field of global health. In total, over US$14.25 billion was raised during the conference, a record-breaking sum to fight deadly diseases and prevent future pandemics.

The COVID-19 pandemic caused increased the suffering and death caused by TB, while TB is curable. The Dutch coalition agreement previously announced that the Netherlands will focus more on the fight against TB and HIV/AIDS.

As a proud partner of the Global Fund, KNCV Tuberculosis Foundation applauds the pledge the Netherlands made to support the Global Fund with € 180 million.

Mustapha Gidado, executive director of KNCV Tuberculosis Foundation: “We would also like to thank the global leaders and captains of private industries for their contributions.
Your support for the 7th Global Fund replenishment will ensure the end of HIV, TB, and Malaria epidemics in your lifetime. Thank you for standing and be counted when it matters most.”

Read more: Dutch Government and Global Fund

Photo: a screenshot of Minister Liesje Schreinemacher during the announcement of the Dutch contribution to the Global Fund.

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.